ADRENALINE AGUETTANT (Juno Pharmaceuticals Pty Ltd)
Product name
ADRENALINE AGUETTANT
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
169 working days (255)
Active ingredients
Adrenaline (epinephrine) as acid tartrate
Registration type
New generic medicine
Indication
ADRENALINE AGUETTANT (solution for injection) is indicated as an adjunct in the management of cardiac arrest.